Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Nav1.7 for the Treatment of Pain
Work
Year: 2021
Type: article
Source: Journal of Medicinal Chemistry
Institutions United States Military Academy, IRBM Science Park, Merck & Co., Inc., Rahway, NJ, USA (United States)
Cites: 52
Cited by: 17
Related to: 10
FWCI: 1.323
Citation percentile (by year/subfield): 53.29
Subfield: Molecular Biology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed